Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 24 articles:
HTML format
Text format

Single Articles

    December 2018
    Targeting Crohn's disease.
    Lancet. 2018;390:2742-2744.
    PubMed     Text format    

  2. COLOMBEL JF, Panaccione R, Bossuyt P, Lukas M, et al
    Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
    Lancet. 2018;390:2779-2789.
    PubMed     Text format     Abstract available

    October 2017
  3. KAMM MA
    Rapid changes in epidemiology of inflammatory bowel disease.
    Lancet. 2017 Oct 13. pii: S0140-6736(17)32669.
    PubMed     Text format    

  4. NG SC, Shi HY, Hamidi N, Underwood FE, et al
    Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Lancet. 2017 Oct 13. pii: S0140-6736(17)32448.
    PubMed     Text format     Abstract available

    July 2017
  5. DE JONG MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, et al
    Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial.
    Lancet. 2017 Jul 14. pii: S0140-6736(17)31327.
    PubMed     Text format     Abstract available

    June 2017
  6. VESELY R, Richardson P
    The switch to infliximab biosimilars.
    Lancet. 2017;389:2266-2268.
    PubMed     Text format    

    May 2017
    Towards therapeutic choices in ulcerative colitis.
    Lancet. 2017 May 17. pii: S0140-6736(17)31263.
    PubMed     Text format    

  8. VERMEIRE S, Sandborn WJ, Danese S, Hebuterne X, et al
    Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 May 17. pii: S0140-6736(17)30930.
    PubMed     Text format     Abstract available

  9. JORGENSEN KK, Olsen IC, Goll GL, Lorentzen M, et al
    Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
    Lancet. 2017 May 11. pii: S0140-6736(17)30068.
    PubMed     Text format     Abstract available

    February 2017
  10. PARAMSOTHY S, Kamm MA, Kaakoush NO, Walsh AJ, et al
    Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Lancet. 2017 Feb 14. pii: S0140-6736(17)30182.
    PubMed     Text format     Abstract available

    Is intensity the solution for FMT in ulcerative colitis?
    Lancet. 2017 Feb 14. pii: S0140-6736(17)30313.
    PubMed     Text format    

    January 2017
    A cure for Crohn's disease by 2032.
    Lancet. 2017;389:226.
    PubMed     Text format    

    Filgotinib for Crohn's disease-expanding treatment options.
    Lancet. 2017;389:228-229.
    PubMed     Text format    

  14. VERMEIRE S, Schreiber S, Petryka R, Kuehbacher T, et al
    Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.
    Lancet. 2017;389:266-275.
    PubMed     Text format     Abstract available

    November 2016
  15. UNGARO R, Mehandru S, Allen PB, Peyrin-Biroulet L, et al
    Ulcerative colitis.
    Lancet. 2016 Nov 30. pii: S0140-6736(16)32126.
    PubMed     Text format     Abstract available

    September 2016
  16. CICCOCIOPPO R, Corazza GR
    Mesenchymal stem cells for fistulising Crohn's disease.
    Lancet. 2016;388:1251-2.
    PubMed     Text format    

  17. PANES J, Garcia-Olmo D, Van Assche G, Colombel JF, et al
    Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
    Lancet. 2016;388:1281-90.
    PubMed     Text format     Abstract available

    July 2016
  18. LYNCH RW, Soane T, Gibson R, Pal S, et al
    Bilateral lower limb weakness in acute severe ulcerative colitis.
    Lancet. 2016;388:101-2.
    PubMed     Text format    

    The inherent dangers of high-dose steroids for acute inflammatory conditions.
    Lancet. 2016;388:102.
    PubMed     Text format    

    February 2016
  20. KHANNA R
    Immunosuppression for management of Crohn's disease - Author's reply.
    Lancet. 2016;387:748.
    PubMed     Text format    

  21. MILOSEVIC I, Dale A, Drysdale H, Mahtani K, et al
    Immunosuppression for management of Crohn's disease.
    Lancet. 2016;387:747.
    PubMed     Text format    

  22. HERFARTH HH, Long MD, Kappelman MD
    Immunosuppression for management of Crohn's disease.
    Lancet. 2016;387:747-8.
    PubMed     Text format    

    October 2015
  23. CLEYNEN I, Boucher G, Jostins L, Schumm LP, et al
    Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
    Lancet. 2015 Oct 16. pii: S0140-6736(15)00465.
    PubMed     Text format     Abstract available

  24. TORRES J, Colombel JF
    Genetics and phenotypes in inflammatory bowel disease.
    Lancet. 2015 Oct 16. pii: S0140-6736(15)00464.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.